tiprankstipranks
Advertisement
Advertisement

DTIL Stock Latest News

Precision BioSciences Begins First DMD Gene-Editing Trial
Company AnnouncementsPrecision BioSciences Begins First DMD Gene-Editing Trial
5d ago
8K
DTIL
BioSciences doses first patient in Phase 1/2 FUNCTION-DMD clinical trial
PremiumThe Fly
BioSciences doses first patient in Phase 1/2 FUNCTION-DMD clinical trial
5d ago
DTIL
Precision BioSciences to present data from OTC-HOPE trial of ECUR-506
PremiumThe Fly
Precision BioSciences to present data from OTC-HOPE trial of ECUR-506
9d ago
DTIL
Precision BioSciences: Buy Rating Reiterated as ARCUS HBV and DMD Catalysts De-Risk Platform; $60 Price Target Maintained
PremiumRatings
Precision BioSciences: Buy Rating Reiterated as ARCUS HBV and DMD Catalysts De-Risk Platform; $60 Price Target Maintained
17d ago
DTIL
Precision BioSciences reports Q2 EPS ($1.26) vs. ($2.13) last year
PremiumThe Fly
Precision BioSciences reports Q2 EPS ($1.26) vs. ($2.13) last year
23d ago
DTIL
Precision BioSciences sees cash runway through 2028
PremiumThe FlyPrecision BioSciences sees cash runway through 2028
23d ago
DTIL
Precision BioSciences Announces Key Executive Leadership Changes
Premium
Company Announcements
Precision BioSciences Announces Key Executive Leadership Changes
1M ago
8K
DTIL
Precision BioSciences announces changes to its senior leadership team
Premium
The Fly
Precision BioSciences announces changes to its senior leadership team
1M ago
DTIL
Precision BioSciences announces grant of inducement awards
PremiumThe Fly
Precision BioSciences announces grant of inducement awards
2M ago
DTIL
Precision BioSciences Advances Gene-Editing Programs in Hepatitis B
PremiumCompany Announcements
Precision BioSciences Advances Gene-Editing Programs in Hepatitis B
2M ago
8K
DTIL
Precision BioSciences announces addition to the Russell 2000 Index
PremiumThe Fly
Precision BioSciences announces addition to the Russell 2000 Index
2M ago
DTIL
Precision BioSciences Extends Term Loan Maturity to 2029
PremiumCompany Announcements
Precision BioSciences Extends Term Loan Maturity to 2029
2M ago
8K
DTIL
Precision BioSciences initiated with an Outperform at Oppenheimer
PremiumThe FlyPrecision BioSciences initiated with an Outperform at Oppenheimer
3M ago
DTIL
Patrick Trucchio Reiterates Buy on Precision BioSciences with Unchanged $60 Price Target on Promising ELIMINATE-B Data and ARCUS-Based Upside
Premium
Ratings
Patrick Trucchio Reiterates Buy on Precision BioSciences with Unchanged $60 Price Target on Promising ELIMINATE-B Data and ARCUS-Based Upside
3M ago
DTIL
Precision BioSciences Reports Promising New Hepatitis B Trial Data
Premium
Company Announcements
Precision BioSciences Reports Promising New Hepatitis B Trial Data
3M ago
8K
DTIL
Precision BioSciences presents new data from ELIMINATE-B study at EASL
PremiumThe Fly
Precision BioSciences presents new data from ELIMINATE-B study at EASL
3M ago
DTIL
Precision BioSciences Shareholders Approve Incentive Plan and Directors
PremiumCompany Announcements
Precision BioSciences Shareholders Approve Incentive Plan and Directors
3M ago
8K
DTIL
Precision BioSciences announces results from low-dose cohort of ECUR-506
PremiumThe Fly
Precision BioSciences announces results from low-dose cohort of ECUR-506
3M ago
DTIL
Precision BioSciences presents new preclinical data on Pbgene-DMD program
PremiumThe Fly
Precision BioSciences presents new preclinical data on Pbgene-DMD program
4M ago
DTIL
Precision BioSciences sees cash runway through 2028
PremiumThe FlyPrecision BioSciences sees cash runway through 2028
4M ago
DTIL
Precision BioSciences reports Q1 EPS (75c) vs. ($2.21) last year
Premium
The Fly
Precision BioSciences reports Q1 EPS (75c) vs. ($2.21) last year
4M ago
DTIL
Precision BioSciences activates first clinical trial site for PBGENE-DMD
Premium
The Fly
Precision BioSciences activates first clinical trial site for PBGENE-DMD
4M ago
DTIL

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >